|
| Status |
Public on Jun 22, 2019 |
| Title |
LIX1L stabilization of CCL20 promotes fibrosis |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
Expression of LIX1L is increased in fibrotic livers and associated with liver fibrosis stage. We investigated whether increased LIX1L expression promotes Hepatic stellate cells (HSCs) activation and liver fibrosis progression by interacting with Chemokine signaling pathway.
|
| |
|
| Overall design |
LX-2 cells mRNA profiles of 48h transfected with siControl or siLIX1L were generated by RNA sequencing.
|
| |
|
| Contributor(s) |
Zhang H, Zhu X |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| |
| Submission date |
Jun 21, 2019 |
| Last update date |
Aug 09, 2019 |
| Contact name |
xiaoyun zhu |
| E-mail(s) |
[email protected]
|
| Phone |
15951718368
|
| Organization name |
China Pharmaceutical University
|
| Street address |
江苏省南京市中国药科大学
|
| City |
南京 |
| State/province |
10 |
| ZIP/Postal code |
211198 |
| Country |
China |
| |
|
| Platforms (1) |
|
| Samples (5)
|
|
| Relations |
| BioProject |
PRJNA550026 |
| SRA |
SRP202079 |
Less...
More...